The number of patients treated for heart diseases caused by myocardial ischemia sharply grew in Korea over the past five years, significantly increasing medical expenses for their treatment, data showed.According to the National Health Insurance Service, the number of patients with ischemic heart di
Covid-19 patients felt the need for home treatment more than the general public, and nearly half of the patients thought they did not receive good treatment, a survey found.The National Medical Center conducted a public perception survey to establish a response strategy to the prolonged Covid-19 pan
Samsung Medical Center (SMC) said Monday that it has confirmed the efficacy of a combination of cytotoxic chemotherapy and Keytruda (ingredient: pembrolizumab) for esophagus cancer in the global phase 3 clinical trials.The global study, led by Professor Sun Jong-mu of the Department of Hematology an
The Seoul National University Bundang Hospital (SNUBH) said Monday that its researchers have discovered that antidepressants may relieve chronic dizziness.“Most dizziness appears as a temporary symptom, and patients often ignore the symptoms because it subsides,” the hospital said. “However, if the
JW Creagene said Monday that it would cooperate with Oncoinsight to develop the next-generation anticancer cell therapy called CAR-M.Through this collaboration, the two companies will jointly research and develop a CAR-Macrophage (CAR-M). This anticancer cell therapy combines a chimeric antigen rece
The market competition of combination therapies for hypertension and dyslipidemia is likely to heat up, as Yuhan Corp. and JW Pharmaceutical recently won approval for related products.Prescriptions of dyslipidemia combo drugs jumped 21 percent on-year to 633.5 billion won ($536.7 million) in Korea i
Avastin (bevacizumab), a vascular endothelial growth factor (VEGF) inhibitor, is almost a staple in anticancer treatment combined with chemotherapy or immunotherapy in various types of cancer.After Samsung Bioepis’ biosimilar of Avastin became reimbursable in Korea, the government notified that it w
Homegrown antibody biosimilar products are accelerating their penetration into the global market, as two makers -- Samsung Bioepis and Celltrion – have scored 11 approvals in Europe and eight in the U.S.The achievement came eight years after Celltrion won the nod for Remsima (ingredient: infliximab)
Korea's daily Covid-19 tally reached an all-time high on Friday, due mainly to the mass migrations during the Chuseok holiday last week.The Korea Disease Control and Prevention Agency (KDCA) confirmed 2,434 new virus cases, including 2,416 local infections, breaking the previous record of 2,221 on A
Huons has signed an agreement with AriBio, a biotech firm specializing in medicines for neurodegenerative and infectious disease, to develop new brain disease and dementia drugs targeting the global market.The two partners signed an agreement to develop AriBio's treatment candidates for brain diseas
Ildong Group is speeding up preparations to list its affiliate Ildong Bioscience on the stock market.The group said it decided to sell some of its stake in Ildong Bioscience within the limit that does not affect management rights. The move is part of preparations for an initial public offering of Il
The mental health of young women and children has shown the most dangerous signs of all demographic groups since the outbreak of Covid-19 some one-and-a-half years ago, a lawmaker said Friday.The number of women in their 20s and 30s treated for depression and stress has continued to rise throughout
EuBiologics, a Korean Covid-19 vaccine developer, is expected to license out a vaccine adjuvant technology to a U.S. biopharmaceutical company, industry sources said.The vaccine adjuvant market used to be dominated by multinational pharmaceutical companies, but industry officials pay attention to wh
Medibloc said it has launched Dr. Palette, a next-generation cloud-based electronic medical record (EMR) service."Dr. Palette is a product that maximizes user convenience through mobile EMR linked to web EMR web, complete linkage with industrial complex servers, and automatic update of notices and f
Researchers at Seoul National University Hospital (SNUH) have developed a peptide to promote hair growth and suppress hair loss symptoms.Hair loss is a painful condition that affects millions of people worldwide and has various causes such as aging, hormonal disorders, and side effects of various dr
Yuhan Corp.’s new anti-cancer drug Leclaza (ingredient: lazertinib), in combination with Janssen’s Rybrevant (ingredient: amivantamab), raised the response rate and extended the duration of response in advanced non-small cell lung cancer (NSCLC) patients who failed previous treatment.Researchers pre
Cytiva, a U.S. company supplying raw and subsidiary materials for vaccine production, decided to invest $52.5 million in Korea until 2024 to build manufacturing facilities for global capacity expansion.Vaccine developers and research institutes from Korea and the U.S. also agreed to cooperate in dev
Despite the prolonging Covid-19 pandemic, many Korean biopharmaceutical companies took part in the 2021 European Society for Medical Oncology (ESMO) Congress, one of the largest cancer meetings globally, to present their development of pipelines.ESMO presents the latest scientific developments in ba
The health authorities predicted on Thursday that Covid-19 cases might resurge down the road as the impact of a massive population movement during the Chuseok holiday might appear from next week.The Korea Disease Control and Prevention Agency (KDCA) confirmed 1,716 new virus cases, including 1,698 l
Samsung Biologics said Wednesday that it has launched S-Cellerate, a pharmaceutical consignment development organization (CDO) platform that shortens the period for developing drugs, at the 2021 BioProcess International Conference.According to the company, S-Cellerate significantly shortens the time